It’s good to talk, says Europe’s ambitious regulator

February 12, 2004

Europe's medicines regulator has unveiled its new long-term strategy to improve its work on human medicines as it prepares to …

War of words over atypicals link to diabetes

February 5, 2004

Pfizer and Eli Lilly have tried to distance their products from renewed claims that atypical antipsychotics are linked to an …

Strong Roche says no to mergers

February 5, 2004

Roche is set for a strong return to growth in 2004 and says it should be counted out of growing …

AZ switches Symbicort agency

February 5, 2004

AstraZeneca has taken on a new PR agency to spearhead a new two-year communications campaign for its respiratory brand treatment …

Zeltia to press ahead with rejected cancer drug

February 4, 2004

Zeltia has unveiled a three-year business plan to put itself back on track after lead cancer drug Yondelis was rejected …

Industry chair for communications body

February 3, 2004

Stuart Rose has been named as the new chair of the Healthcare Communications Association (HCA), the first ever from the …

AstraZeneca emerges unscathed from $2.6 billion patent loss

February 3, 2004

Strong growth in a new generation of products has helped AstraZeneca earn a memorable victory in overcoming $2.6 billion worth …

Managing medical education

February 3, 2004

Over the years, Medical Education (med ed) and PR agencies have been an invaluable part of the marketing mix. Med …

Sanofi makes takeover bid for ‘weakened’ Aventis

January 26, 2004

Sanofi-Synthelabo has made a pre-emptive E47 billion takeover bid for Aventis with the aim of creating the world's third-biggest drugmaker …

Pfizer takes giant step forward

January 23, 2004

The pharmaceutical industry's biggest company Pfizer has restated its dominance with renewed growth in sales and earnings for the fourth …

Abbott raises sales expectations for Humira

January 21, 2004

Abbott Laboratories has raised its sales forecast for Humira, its new rheumatoid arthritis treatment, to $700 million in 2004 after …

Pfizer to sell diagnostics business

January 21, 2004

Pfizer has agreed to sell its Swedish in-vitro allergy and autoimmune diagnostic business to private equity groups Triton and PPM …

Aventis and Sanofi attempt to quash merger rumours

January 19, 2004

Sanofi-Synthelabo and Aventis have been forced to officially deny they are in merger talks after speculation sent shares soaring in …

Streamlined research

January 19, 2004

For many years the pharmaceutical industry has been promising that they were on the verge of a boom in the …

The Gateway to Local Adoption Series

Latest content